UK small-cap RNS · 15 Jul 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Sort: Newest · Largest companies
-
17:15
Supermarket Income Reit SUPR £1,141mResults of the Issue ResultsRaises £100m gross at 83p, a discount to NAV, to fund the £216m nine-asset pipeline alongside leverage. Growth funding is secured, but the new shares are about 10% of the existing capital and dilute holders.Moved: Debt-funded UK pipeline deployment: Three-store contracts exchanged; completion due September → Equity raise priced; awaiting shareholder approval
-
13:55
-
13:30
Supermarket Income Reit SUPR £1,141mAcquisition of three supermarkets for £118 millionContracts are exchanged for three supermarkets at £118m and a 6.9% NIY, due to complete in September 2026. It is the first leg of the debt- and equity-funded pipeline, so completion is still pending and funding relies on the equity raise.Moved: Debt-funded UK pipeline deployment: Retail offer launched alongside placings → Three-store contracts exchanged; completion due September
-
12:11
-
10:12
-
09:54
-
09:30
-
07:45
MoU for sale of 50 MWp for EUR 12 millionFirst monetisation of the Italian solar portfolio: EUR 12m for about 50 MWp of Piedmont projects against about EUR 5m cost, giving non-dilutive cash. It is a non-binding MoU, subject to due diligence.Moved: Partial sale of solar portfolio: Advanced discussions on one project → Non-binding MoU signed; due diligence pending
-
07:02
Supermarket Income Reit SUPR £1,141mRetail Offer FundraiseRetail tranche of the c.£100m raise funds the £118m three-supermarket purchase and a further £98m pipeline, which the company calls earnings accretive, but it dilutes existing holders. Shares carry no Q4 dividend.Large acquisition / reverse takeover −2.7% on the dayMoved: Debt-funded UK pipeline deployment: £100m equity raise launched to fund pipeline → Retail offer launched alongside placings
-
07:00
Kropz KRPZ £7.0mNew Loan Facility and Operational UpdateA new ZAR 200m on-demand loan from the related party UBI, repayable on 15 business days' notice and priced at prime plus 6%, is needed to cover working capital after operational problems. Funding need is growing and lender dependence is deepening.Moved: Elandsfontein trial production ramp-up: Record March output; still in trial production → Q2 output down 17% after March record · Funding via ARC on-demand loans: Loan amended; ZAR 150m drawn, about ZAR 80m left → New ZAR 200m UBI loan agreed
-
07:00
Distil DIS £1.2mDirectorate Change Board changeExecutive Chairman Don Goulding retires after 16 years, ending the combined role. The split removes concentration of power, but the change comes after a weak Q4 and a funding squeeze.Moved: new: Board and leadership reshuffle – Announced; CEO appointment subject to due diligence
-
07:00
Supermarket Income Reit SUPR £1,141mProposed equity issue to fund acquisitionsRaises about £100m of new equity (placing, South African placing, retail offer) to fund £216m of acquisitions, so the portfolio grows and earnings should rise, but existing holders are diluted. The shares trade at a premium to NAV.Moved: Debt-funded UK pipeline deployment: JV proceeds fully redeployed; LTV 43% pro-forma → £100m equity raise launched to fund pipeline
-
07:00
Results for the year ended 31 March 2026 ResultsFull-year results beat the March 'materially ahead' guidance: adjusted EBITDA £8.5m, about 5% above consensus, on 10% revenue growth and higher margins. This confirms the upgrade already made, not a new raise.Moved: ECOVAXXIN MS US and UK approvals: USDA accepted pivotal efficacy study; UK dossier awaiting submission → EU approved and launched; US approval expected · ECOVAXXIN MG US approval: USDA safety assessment favourable → USDA safety assessment favourable; submission H1 2028
-
07:00
-
07:00
Hunting HTG £585mH1 2026 Trading Update Trading updateH1 EBITDA of c.$62m fits the 40:60 phasing and the $145-155m guidance is only maintained. Perforating Systems and Subsea are ahead, but OCTG and Advanced Manufacturing are lower on phasing, leaving H2 to deliver.Moved: CEO succession: Nomination Committee search under way → Search firm appointed; global search under way · EMEA restructuring: On track; cost programme accelerating, segments to merge → Aberdeen OCTG moving to Badentoy; Fordoun closing · Share buyback programme: Ongoing; second $40m proposed → Second buyback under way; $6.0m done in H1
-
07:00
Cropper (James) CRPR £76mFinal Results ResultsFinal results confirm the £8.9m Adjusted EBITDA already flagged in April (£8.8m), with net debt a little better; the Board's FY27 expectations are underpinned, not raised, so it is confirmation rather than an upgrade.Moved: Paper & Packaging turnaround: H2 FY26 EBITDA profit; losses sharply reduced → H2 EBITDA profit; FY26 loss narrowed to £0.5m
-
07:00
Ferrexpo FXPO £341mProduction Report for 2Q 2026 & Trading Update Trading updateFerrexpo plc (LSE: FXPO), a producer and exporter of premium iron ore products, reports production results for the second quarter to the end of June 2026 ("the quarter" or "2Q" or "2Q 2026") alongside a general trading and corporate update.Dilutive fundraise +0.0% on the day
-
07:00
Workspace Group WKP £637mFirst Quarter Business UpdateFirst quarter under the new plan shows stabilised occupancy and rent roll recovering, but the conversion rate is lower (14% vs 15%) and enquiries and viewings are down year on year. Much of the rent roll gain is offset by disposals.Moved: Low-conviction building disposals: Disposals continuing; more discounts disclosed → £138.4m exchanged or completed against £200m target · Saba Capital board requisition: Board rebutting Saba's updated materials before AGM → Board urging votes against Saba before AGM · Fix, Accelerate and Scale turnaround: Strategy update and FY results delivered → Execution begun; first quarter shows modest recovery
-
07:00
CelLBxHealth plc CLBX £6.8mQ2 and First Half Year Results ended 30 June 2026 ResultsThe restructuring cut the operating loss to £2.7m from £9.7m and Q2 revenue doubled, but H1 revenue fell to £0.6m and cash dropped to £2.9m with runway only into Q2 2027.Moved: Restructuring and turnaround: CEO exit; search for successor begins → Costs cut; CEO search under way · Equity fundraise: Completed December 2025; funds support runway to Q2 2027 → Cash £2.9m; runway into Q2 2027
-
07:00
Vast Resources VAST £62mUpdate on proposed RTO and General UpdateThe Gulf reverse takeover advances: due diligence is near-complete and Tajikistan has confirmed the Aprelevka organisational changes. Completion still hinges on the Placing, and the sellers get 80%, so dilution is heavy.Balance-sheet stress / refinancing +0.0% on the dayMoved: Gulf International Minerals reverse takeover: Longstop extended to 31 July 2026; shares suspended → Due diligence near-complete; long-stop 31 July 2026 · Alpha and Mercuria loan default: Extension to RTO completion under discussion, not agreed → Extension talks continuing; not agreed · Zimbabwe diamond parcel sale: Antwerp channel set up; sales due to start → Update promised shortly; no results given
-
07:00
Q2 2026 Operations and Financial UpdatesProduction is said to be 3% ahead of budget and the 12,000 bopd annual guidance is reaffirmed, so nothing is raised. Q2 output of 12,557 bopd is down from 14,907 bopd in Q1, and workovers are due in Q3.Moved: Bretana erosion control project: Re-tender underway; award slipped to end June → Still in contractor discussions; no award announced · Dividend suspension and cash preservation: Cash stable; EBITDA guidance raised on price → Cash up on rig sale; dividend still suspended · Bretana drilling restart and water handling: Drilling contract signed; rig mobilisation planned → Workovers starting; drilling prep well advanced
-
07:00
Cohort CHRT £594mFinal Results ResultsFinal FY26 results confirm record revenue £306.4m and adjusted operating profit £36.3m (+32%), ahead of expectations, after weak interims; slightly above the May update's c.£303m and c.£36m.Moved: Second-half weighted delivery and margin recovery: H2 delivery achieved, FY26 ahead of expectations → FY26 final results confirm H2 delivery
-
07:00
Dr. Martens DOCS £628mAGM Trading Update Trading updateConfirms FY27 trading and guidance are unchanged after the strong FY26 PBT rebound, with US wholesale and Asia supportive. Europe is soft, so this is reassurance rather than an upgrade.Moved: Levers for Growth strategy: Pivot phase done; scale phase starting FY27 → Scale phase, on track in early FY27
-
07:00
GETECH Group GTC £6.6mNew Contract Win with European Energy Super-MajorAdds a three-year Globe contract with a fifth super-major, worth $660k as annual recurring revenue. This supports the ARR priority after flat ARR at £2.8m, and shows the larger pipeline converting. The contract is small.Moved: Turnaround and refocus on core markets: H1 revenue and EBITDA up; ARR flat → Pipeline converting; ARR priority supported by new Globe win